CAT2 arginine transporter deficiency significantly reduces iNOS‐mediated NO production in astrocytes

We have previously demonstrated that genetic ablation of cationic amino acid transporter 2 (Cat2) significantly inhibits nitric oxide (NO) production by inducible nitric oxide synthase (iNOS) in activated macrophages. Here we report that iNOS activity is impaired by 84% in activated Cat2‐deficient astrocytes. Cat2 ablation appears to reduce astrocyte NO synthesis by decreasing the uptake of the sole precursor, arginine, as well as by reducing the expression of iNOS following activation. Excessive or dysregulated NO production by activated astrocytes and other CNS cell types has been implicated in the pathogenesis of neurological disorders. Our results support the idea that manipulation of CAT2 transporter function might be useful for the therapeutic modulation of iNOS activity.

[1]  C. Macleod,et al.  Cat2 L-arginine transporter-deficient fibroblasts can sustain nitric oxide production. , 2002, Nitric oxide : biology and chemistry.

[2]  E. Getzoff,et al.  Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and III* , 2002, The Journal of Biological Chemistry.

[3]  B. Stevens,et al.  Interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcription. , 2002, Nitric oxide : biology and chemistry.

[4]  T. Uliasz,et al.  Differential modulation of prostaglandin H synthase-2 by nitric oxide-related species in intact cells. , 2001, Biochemistry.

[5]  T. Klockgether,et al.  Neuronal and Glial Coexpression of Argininosuccinate Synthetase and Inducible Nitric Oxide Synthase in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[6]  K. Abe,et al.  Inducible Nitric Oxide Synthase (iNOS) and Nitrotyrosine Immunoreactivity in the Spinal Cords of Transgenic Mice with a G93A Mutant SOD1 Gene , 2001, Journal of neuropathology and experimental neurology.

[7]  T. Gotoh,et al.  Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain. , 2001, Brain research. Molecular brain research.

[8]  H. Wiesinger.  Arginine metabolism and the synthesis of nitric oxide in the nervous system , 2001, Progress in Neurobiology.

[9]  C. Brosnan,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.

[10]  C. Macleod,et al.  Sustained Nitric Oxide Production in Macrophages Requires the Arginine Transporter CAT2* , 2001, The Journal of Biological Chemistry.

[11]  Sunhee C. Lee,et al.  Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis , 2001, Journal of Neuroimmunology.

[12]  U. Förstermann,et al.  Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. , 2000, Molecular pharmacology.

[13]  K. Fujiwara,et al.  Neuron-specific expression of cationic amino acid transporter 3 in the adult rat brain , 1999, Brain Research.

[14]  T. Gotoh,et al.  L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. , 1999, Brain research. Molecular brain research.

[15]  S. Hewett.  Interferon-γ reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation , 1999, Journal of Neuroimmunology.

[16]  D. Dickson,et al.  Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain , 1998, Brain Research.

[17]  C. Macleod,et al.  Stress differentially induces cationic amino acid transporter gene expression. , 1998, Biochimica et biophysica acta.

[18]  S. Heales,et al.  Increased inducible nitric oxide synthase protein but limited nitric oxide formation occurs in astrocytes of the hph-1 (tetrahydrobiopterin deficient) mouse , 1998, Brain Research.

[19]  C. Macleod,et al.  Increased Cat3-mediated Cationic Amino Acid Transport Functionally Compensates in Cat1 Knockout Cell Lines* , 1998, The Journal of Biological Chemistry.

[20]  D. Mattson,et al.  Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line , 1998, Journal of Neuroimmunology.

[21]  E. Block,et al.  A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”* , 1997, The Journal of Biological Chemistry.

[22]  A. Cross,et al.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination , 1997, Journal of Neuroimmunology.

[23]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[24]  M. N. Wallace,et al.  Nitric Oxide Synthase in Reactive Astrocytes Adjacent to β-Amyloid Plaques , 1997, Experimental Neurology.

[25]  T. Owens,et al.  Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.

[26]  J. Cunningham,et al.  Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. , 1997, Genes & development.

[27]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[28]  A. Cross,et al.  Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.

[29]  M. Raizada,et al.  Induced Nitric Oxide Synthesis Is Dependent on Induced Alternatively Spliced CAT-2 Encoding L-Arginine Transport in Brain Astrocytes* , 1996, The Journal of Biological Chemistry.

[30]  C. Macleod.  Regulation of cationic amino acid transporter (CAT) gene expression. , 1996, Biochemical Society transactions.

[31]  B. C. Low,et al.  Interleukin-1 and Tumor Necrosis Factor- Stimulate the cat-2 Gene of the L-Arginine Transporter in Cultured Vascular Smooth Muscle Cells (*) , 1996, The Journal of Biological Chemistry.

[32]  O. Bagasra,et al.  Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Moncada,et al.  Molecular mechanisms and therapeutic strategies related to nitric oxide , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  S. Sakoda,et al.  Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.

[35]  H. Wiesinger,et al.  Stimulation of Arginine Transport and Nitric Oxide Production by Lipopolysaccharide Is Mediated by Different Signaling Pathways in Astrocytes , 1995, Journal of neurochemistry.

[36]  R. Prior,et al.  Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. , 1995, Analytical biochemistry.

[37]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[38]  H. Wiesinger,et al.  Transport of L‐arginine in cultured glial cells , 1994, Glia.

[39]  M. Mcdaniel,et al.  Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes , 1993, Neuroscience Letters.

[40]  M. Simmons,et al.  Induction of Nitric Oxide Synthase in Glial Cells , 1992, Journal of neurochemistry.

[41]  U. Linne,et al.  Microalgae as bioreactors for bioplastic production , 2011, Microbial cell factories.